Literature DB >> 21898064

A case of very late-onset systemic lupus erythematosus and updated pooled analysis of late-onset cases in the literature.

Fang Chen1, Lu Zhang, Guochun Wang, Bing Lin, Liying Wang.   

Abstract

Systemic lupus erythematosus predominantly affects young women during childbearing age. It is rare after the age of 90, and there is no report of very late onset in persons over 90 in China. Here, we reported a case of a female patient, the onset age of whom was 90, analyzing her clinical features and treatments. And when conducting a pooled analysis of late-onset cases in the literature, we found that the organ damages and severity of lupus disease of old-onset SLE were not benign, and considering their ages, comorbidities and high rate of mortalities, appropriate interventions and close follow-up for this age group are needed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21898064     DOI: 10.1007/s00296-011-2103-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

Review 1.  Changes in immune function with age.

Authors:  R L Yung
Journal:  Rheum Dis Clin North Am       Date:  2000-08       Impact factor: 2.670

2.  Cardiac tamponade as the first manifestation of systemic lupus erythematosus in the elderly.

Authors:  Alfonso Gutiérrez-Macías; Eva Lizarralde-Palacios; Sandra Cabeza-García; Felipe Miguel-De la Villa
Journal:  Am J Med Sci       Date:  2006-06       Impact factor: 2.378

3.  A meta-analysis of the clinical manifestations of older-onset systemic lupus erythematosus.

Authors:  M M Ward; R P Polisson
Journal:  Arthritis Rheum       Date:  1989-10

4.  Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. SLE Disease Activity Index.

Authors:  F Formiga; I Moga; M Pac; F Mitjavila; A Rivera; R Pujol
Journal:  Lupus       Date:  1999       Impact factor: 2.911

5.  Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

Authors:  N Kanda; T Tsuchida; K Tamaki
Journal:  Arthritis Rheum       Date:  1999-02

6.  Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients.

Authors:  M H Houman; M Smiti-Khanfir; I Ben Ghorbell; M Miled
Journal:  Lupus       Date:  2004       Impact factor: 2.911

7.  Systemic lupus erythematosus in the elderly: clinical and immunological characteristics.

Authors:  J Font; L Pallarés; R Cervera; A López-Soto; M Navarro; X Bosch; M Ingelmo
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

8.  A case of very-late-onset systemic lupus erythematosus.

Authors:  Ken Yamaji; Mitsunori Yasuda; Kwang Seok Yang; Yoshinori Kanai; Chiharu Yamaji; Toshiaki Kawanishi; Masayuki Toumyo; Kazuhiko Funabiki; Hiroshi Tsuda; Yoshinari Takasaki
Journal:  Mod Rheumatol       Date:  2007-10-19       Impact factor: 3.023

Review 9.  Systemic lupus erythematosus in the elderly.

Authors:  J Rovenský; A Tuchynová
Journal:  Autoimmun Rev       Date:  2007-12-03       Impact factor: 9.754

10.  Late onset systemic lupus erythematosus: no substantial differences using different cut-off ages.

Authors:  Melissa Padovan; Marcello Govoni; Gabriella Castellino; Nicoletta Rizzo; Maria Fotinidi; Francesco Trotta
Journal:  Rheumatol Int       Date:  2006-12-29       Impact factor: 3.580

View more
  2 in total

1.  Successful treatment of massive ascites due to lupus peritonitis with hydroxychloroquine in old- onset lupus erythematosus.

Authors:  Sonia Hammami; Fethia Bdioui; Afef Ouaz; Hichem Loghmari; Sylvia Mahjoub; Hamouda Saffar
Journal:  Pan Afr Med J       Date:  2014-06-19

2.  Adverse Events Associated With Treatment of Tripterygium wilfordii Hook F: A Quantitative Evidence Synthesis.

Authors:  Yi Ru; Ying Luo; Yaqiong Zhou; Le Kuai; Xiaoying Sun; Meng Xing; Liu Liu; Yi Lu; Seokgyeong Hong; Xi Chen; Jiankun Song; Yue Luo; Xiaoya Fei; Bin Li; Xin Li
Journal:  Front Pharmacol       Date:  2019-11-06       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.